Adding selinexor to ifosfamide, etoposide and desametasone does not improve the outcome in relapsed and refractory peripheral T-cell lymphomas: First report of phase II S-ide study.
Year: 2025
Type: conference-abstract
Source: Blood
Institutions: Fondazione IRCCS Istituto Nazionale dei Tumori, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo, Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, University of Turin, University of Pavia, Policlinico San Matteo Fondazione, University of Bari Aldo Moro, University of Milan
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417018958
Cites:
Cited by:
Related to: